Serum tumor biomarkers, including carcinoembryonic antigen (CEA), α-fetoprotein (AFP), and carbohydrate antigen 19-9 (CA19-9), are often used for gastrointestinal tumor detection, but their sensitivities and specificities are not sufficient for the early diagnosis of gastric cancer. This evidence concerns the gene AFP and gastric cancer.